Osteal macrophages: A new twist on coupling during bone dynamics

Bone

Volumn 43, Issue 6, 2008, Pages 976-982

  Pettit, Allison R ^a   Chang, Ming K ^a   Hume, David A ^b   Raggatt, Liza Jane ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Bone modelling; Bone remodelling; Macrophage; Osteoblast; Osteoimmunology

Indexed keywords

ADAPTIVE IMMUNITY; BONE MATURATION; BONE MINERALIZATION; BONE REMODELING; DYNAMICS; HOMEOSTASIS; INNATE IMMUNITY; MACROPHAGE; NONHUMAN; OSSIFICATION; OSTEOBLAST; OSTEOCLAST; PERIOSTEUM; REVIEW;

BONE AND BONES; BONE REMODELING; CALCIFICATION, PHYSIOLOGIC; HUMANS; MACROPHAGES;

EID: 57049093809     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2008.08.128     Document Type: Review

References (87)

1. Goldring S.R. Pathogenesis of bone and cartilage destruction in rheumatoid arthritis. Rheumatol. (Oxford) 42 Suppl 2 (2003) ii11-ii16
2. Hume D.A., Ross I.L., Himes S.R., Sasmono R.T., Wells C.A., and Ravasi T. The mononuclear phagocyte system revisited. J. Leukoc. Biol. 72 (2002) 621-627
3. Bonifer C., and Hume D.A. The transcriptional regulation of the colony-stimulating factor 1 receptor (csf1r) gene during hematopoiesis. Front Biosci. 13 (2008) 549-560
4. Gordon S., and Taylor P.R. Monocyte and macrophage heterogeneity. Nat. Rev. Immunol. 5 (2005) 953-964
5. Davis E.J., Foster T.D., and Thomas W.E. Cellular forms and functions of brain microglia. Brain Res. Bull. 34 (1994) 73-78
6. Kolios G., Valatas V., and Kouroumalis E. Role of Kupffer cells in the pathogenesis of liver disease. World J. Gastroenterol. 12 (2006) 7413-7420
7. Hume D.A. The mononuclear phagocyte system. Curr. Opin. Immunol. 18 (2006) 49-53
8. Taylor P.R., Martinez-Pomares L., Stacey M., Lin H.H., Brown G.D., and Gordon S. Macrophage receptors and immune recognition. Annu. Rev. Immunol. 23 (2005) 901-944
9. Boyle W.J., Simonet W.S., and Lacey D.L. Osteoclast differentiation and activation. Nature 423 (2003) 337-342
10. Gordon S. Alternative activation of macrophages. Nat. Rev. Immunol. 3 (2003) 23-35
11. Theurl I., Fritsche G., Ludwiczek S., Garimorth K., Bellmann-Weiler R., and Weiss G. The macrophage: a cellular factory at the interphase between iron and immunity for the control of infections. Biometals 18 (2005) 359-367
12. Cecchini M.G., Dominguez M.G., Mocci S., Wetterwald A., Felix R., Fleisch H., et al. Role of colony stimulating factor-1 in the establishment and regulation of tissue macrophages during postnatal development of the mouse. Development 120 (1994) 1357-1372
13. Austyn J.M., and Gordon S. F4/80, a monoclonal antibody directed specifically against the mouse macrophage. Eur. J. Immunol. 11 (1981) 805-815
14. Lean J.M., Matsuo K., Fox S.W., Fuller K., Gibson F.M., Draycott G., et al. Osteoclast lineage commitment of bone marrow precursors through expression of membrane-bound TRANCE. Bone 27 (2000) 29-40
15. Bourque W.T., Gross M., and Hall B.K. Expression of four growth factors during fracture repair. Int. J. Dev. Biol. 37 (1993) 573-579
16. Hankemeier S., Grassel S., Plenz G., Spiegel H.U., Bruckner P., and Probst A. Alteration of fracture stability influences chondrogenesis, osteogenesis and immigration of macrophages. J. Orthop. Res. 19 (2001) 531-538
17. Smith J.D., Trogan E., Ginsberg M., Grigaux C., Tian J., and Miyata M. Decreased atherosclerosis in mice deficient in both macrophage colony-stimulating factor (op) and apolipoprotein E. Proc. Natl. Acad. Sci. U. S. A. 92 (1995) 8264-8268
18. Tintut Y., Patel J., Territo M., Saini T., Parhami F., and Demer L.L. Monocyte/macrophage regulation of vascular calcification in vitro. Circulation 105 (2002) 650-655
19. Shioi A., Katagi M., Okuno Y., Mori K., Jono S., Koyama H., et al. Induction of bone-type alkaline phosphatase in human vascular smooth muscle cells: roles of tumor necrosis factor-alpha and oncostatin M derived from macrophages. Circ. Res. 91 (2002) 9-16
20. van Lent P.L., Blom A.B., van der Kraan P., Holthuysen A.E., Vitters E., van Rooijen N., et al. Crucial role of synovial lining macrophages in the promotion of transforming growth factor beta-mediated osteophyte formation. Arthritis Rheum. 50 (2004) 103-111
21. Blom A.B., van Lent P.L., Holthuysen A.E., van der Kraan P.M., Roth J., van Rooijen N., et al. Synovial lining macrophages mediate osteophyte formation during experimental osteoarthritis. Osteoarthr. Cartil. 12 (2004) 627-635
22. Kamekura S., Hoshi K., Shimoaka T., Chung U., Chikuda H., Yamada T., et al. Osteoarthritis development in novel experimental mouse models induced by knee joint instability. Osteoarthr. Cartil. 13 (2005) 632-641
23. Kaneko M., Tomita T., Nakase T., Ohsawa Y., Seki H., Takeuchi E., et al. Expression of proteinases and inflammatory cytokines in subchondral bone regions in the destructive joint of rheumatoid arthritis. Rheumatol. (Oxford) 40 (2001) 247-255
24. Haynes D.R., Hay S.J., Rogers S.D., Ohta S., Howie D.W., and Graves S.E. Regulation of bone cells by particle-activated mononuclear phagocytes. J. Bone Joint. Surg. Br. 79 (1997) 988-994
25. Cenci S., Weitzmann M.N., Gentile M.A., Aisa M.C., and Pacifici R. M-CSF neutralization and egr-1 deficiency prevent ovariectomy-induced bone loss. J. Clin. Invest. 105 (2000) 1279-1287
26. Champagne C.M., Takebe J., Offenbacher S., and Cooper L.F. Macrophage cell lines produce osteoinductive signals that include bone morphogenetic protein-2. Bone 30 (2002) 26-31
27. Tran Van P., Vignery A., and Baron R. An electron-microscopic study of the bone-remodeling sequence in the rat. Cell Tissue Res. 225 (1982) 283-292
28. Hume D.A., Loutit J.F., and Gordon S. The mononuclear phagocyte system of the mouse defined by immunohistochemical localization of antigen F4/80: macrophages of bone and associated connective tissue. J. Cell Sci. 66 (1984) 189-194
29. Chang M.K., Raggatt L.J., Alexander K.A., Kuliwaba J.S., Fazzalari N.L., Schroder K., et al. Osteal tissue macrophages are intercalated throughout human and mouse bone lining tissues and regulate osteoblast function in vitro and in vivo. J. Immunol. 181 (2008) 1232-1244
30. Heinemann D.E., Lohmann C., Siggelkow H., Alves F., Engel I., and Koster G. Human osteoblast-like cells phagocytose metal particles and express the macrophage marker CD68 in vitro. J. Bone Jt. Surg., Br. 82 (2000) 283-289
31. Ruiz C., Perez E., Vallecillo-Capilla M., and Reyes-Botella C. Phagocytosis and allogeneic T cell stimulation by cultured human osteoblast-like cells. Cell Physiol. Biochem. 13 (2003) 309-314
32. Kikuchi T., Matsuguchi T., Tsuboi N., Mitani A., Tanaka S., Matsuoka M., et al. Gene expression of osteoclast differentiation factor is induced by lipopolysaccharide in mouse osteoblasts via Toll-like receptors. J. Immunol. 166 (2001) 3574-3579
33. Maruyama K., Sano G., and Matsuo K. Murine osteoblasts respond to LPS and IFN-gamma similarly to macrophages. J. Bone Miner. Metab. 24 (2006) 454-460
34. Reyes-Botella C., Montes M.J., Vallecillo-Capilla M.F., Olivares E.G., and Ruiz C. Expression of molecules involved in antigen presentation and T cell activation (HLA-DR, CD80, CD86, CD44 and CD54) by cultured human osteoblasts. J. Periodontol. 71 (2000) 614-617
35. Ruiz C., Perez E., Garcia-Martinez O., Diaz-Rodriguez L., Arroyo-Morales M., and Reyes-Botella C. Expression of cytokines IL-4, IL-12, IL-15, IL-18, and IFNgamma and modulation by different growth factors in cultured human osteoblast-like cells. J. Bone. Miner. Metab. 25 (2007) 286-292
36. Heinemann D.E., Siggelkow H., Ponce L.M., Viereck V., Wiese K.G., and Peters J.H. Alkaline phosphatase expression during monocyte differentiation. Overlapping markers as a link between monocytic cells, dendritic cells, osteoclasts and osteoblasts. Immunobiology 202 (2000) 68-81
37. Zreiqat H., Kumar R.K., Markovic B., Zicat B., and Howlett C.R. Macrophages at the skeletal tissue-device interface of loosened prosthetic devices express bone-related genes and their products. J. Biomed. Mater. Res. A 65 (2003) 109-117
38. Kuwana M., Okazaki Y., Kodama H., Izumi K., Yasuoka H., Ogawa Y., et al. Human circulating CD14+ monocytes as a source of progenitors that exhibit mesenchymal cell differentiation. J. Leukoc. Biol. 74 (2003) 833-845
39. Olmsted-Davis E.A., Gugala Z., Camargo F., Gannon F.H., Jackson K., Kienstra K.A., et al. Primitive adult hematopoietic stem cells can function as osteoblast precursors. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 15877-15882
40. Takeshita S., Kaji K., and Kudo A. Identification and characterization of the new osteoclast progenitor with macrophage phenotypes being able to differentiate into mature osteoclasts. J. Bone Miner. Res. 15 (2000) 1477-1488
41. Haynes D.R., Crotti T.N., Loric M., Bain G.I., Atkins G.J., and Findlay D.M. Osteoprotegerin and receptor activator of nuclear factor kappaB ligand (RANKL) regulate osteoclast formation by cells in the human rheumatoid arthritic joint. Rheumatol. (Oxford) 40 (2001) 623-630
42. Hodge J.M., Kirkland M.A., Aitken C.J., Waugh C.M., Myers D.E., Lopez C.M., et al. Osteoclastic potential of human CFU-GM: biphasic effect of GM-CSF. J. Bone Miner. Res. 19 (2004) 190-199
43. Arai F., Miyamoto T., Ohneda O., Inada T., Sudo T., Brasel K., et al. Commitment and differentiation of osteoclast precursor cells by the sequential expression of c-Fms and receptor activator of nuclear factor kappa B (RANK) receptors. J. Exp. Med. 190 (1999) 1741-1754
44. Stacey K.J., Sweet M.J., and Hume D.A. Macrophages ingest and are activated by bacterial DNA. J. Immunol. 157 (1996) 2116-2122
45. Kobayashi K., Takahashi N., Jimi E., Udagawa N., Takami M., Kotake S., et al. Tumor necrosis factor alpha stimulates osteoclast differentiation by a mechanism independent of the ODF/RANKL-RANK interaction. J. Exp. Med. 191 (2000) 275-285
46. Itoh K., Udagawa N., Kobayashi K., Suda K., Li X., Takami M., et al. Lipopolysaccharide promotes the survival of osteoclasts via Toll-like receptor 4, but cytokine production of osteoclasts in response to lipopolysaccharide is different from that of macrophages. J. Immunol. 170 (2003) 3688-3695
47. Jimi E., Nakamura I., Duong L.T., Ikebe T., Takahashi N., Rodan G.A., et al. Interleukin 1 induces multinucleation and bone-resorbing activity of osteoclasts in the absence of osteoblasts/stromal cells. Exp. Cell. Res. 247 (1999) 84-93
48. van Holten J., Smeets T.J., Blankert P., and Tak P.P. Expression of interferon beta in synovial tissue from patients with rheumatoid arthritis: comparison with patients with osteoarthritis and reactive arthritis. Ann. Rheum. Dis. 64 (2005) 1780-1782
49. Takayanagi H., Kim S., Matsuo K., Suzuki H., Suzuki T., Sato K., et al. RANKL maintains bone homeostasis through c-Fos-dependent induction of interferon-beta. Nature 416 (2002) 744-749
50. Sabit R., Bolton C.E., Edwards P.H., Pettit R.J., Evans W.D., McEniery C.M., et al. Arterial stiffness and osteoporosis in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care. Med. 175 (2007) 1259-1265
51. Walther F., Fusch C., Radke M., Beckert S., and Findeisen A. Osteoporosis in pediatric patients suffering from chronic inflammatory bowel disease with and without steroid treatment. J. Pediatr. Gastroenterol. Nutr. 43 (2006) 42-51
52. Wactawski-Wende J. Periodontal diseases and osteoporosis: association and mechanisms. Ann. Periodontol. 6 (2001) 197-208
53. Bongiovanni M., and Tincati C. Bone diseases associated with human immunodeficiency virus infection: pathogenesis, risk factors and clinical management. Curr. Mol. Med. 6 (2006) 395-400
54. Rodan G.A., and Martin T.J. Role of osteoblasts in hormonal control of bone resorption-a hypothesis. Calcif. Tissue Int. 33 (1981) 349-351
55. Suda T., Takahashi N., and Martin T.J. Modulation of osteoclast differentiation. Endocr. Rev. 13 (1992) 66-80
56. Martin T.J., and Sims N.A. Osteoclast-derived activity in the coupling of bone formation to resorption. Trends Mol. Med. 11 (2005) 76-81
57. James C.G., Appleton C.T., Ulici V., Underhill T.M., and Beier F. Microarray analyses of gene expression during chondrocyte differentiation identifies novel regulators of hypertrophy. Mol. Biol. Cell. 16 (2005) 5316-5333
58. Assoian R.K., Fleurdelys B.E., Stevenson H.C., Miller P.J., Madtes D.K., Raines E.W., et al. Expression and secretion of type beta transforming growth factor by activated human macrophages. Proc. Natl. Acad. Sci. U. S. A. 84 (1987) 6020-6024
59. Takahashi F., Takahashi K., Shimizu K., Cui R., Tada N., Takahashi H., et al. Osteopontin is strongly expressed by alveolar macrophages in the lungs of acute respiratory distress syndrome. Lung 182 (2004) 173-185
60. Kreutz M., Andreesen R., Krause S.W., Szabo A., Ritz E., and Reichel H. 1,25-dihydroxyvitamin D3 production and vitamin D3 receptor expression are developmentally regulated during differentiation of human monocytes into macrophages. Blood 82 (1993) 1300-1307
61. Wynn T.A. Cellular and molecular mechanisms of fibrosis. J. Pathol. 214 (2008) 199-210
62. Kohan M., Bader R., Puxeddu I., Levi-Schaffer F., Breuer R., and Berkman N. Enhanced osteopontin expression in a murine model of allergen-induced airway remodelling. Clin. Exp. Allergy. 37 (2007) 1444-1454
63. Thammasitboon K., Goldring S.R., and Boch J.A. Role of macrophages in LPS-induced osteoblast and PDL cell apoptosis. Bone 38 (2006) 845-852
64. Grundnes O., and Reikeraas O. Effects of macrophage activation on bone healing. J. Orthop. Sci. 5 (2000) 243-247
65. Hattner R., Epker B.N., and Frost H.M. Suggested sequential mode of control of changes in cell behaviour in adult bone remodelling. Nature 206 (1965) 489-490
66. Dempster D.W. Anatomy and Functions of the Adult Skeleton. In: Murray J.F. (Ed). Primer on the metabolic bone diseases and disorders of mineral metabolism. sixth edition ed. (2006), American Society for Bone and Mineral Research, Washington, D.C. 7-11
67. Burnett S.H., Kershen E.J., Zhang J., Zeng L., Straley S.C., Kaplan A.M., et al. Conditional macrophage ablation in transgenic mice expressing a Fas-based suicide gene. J. Leukoc. Biol. 75 (2004) 612-623
68. Mundy G.R., and Elefteriou F. Boning up on ephrin signaling. Cell 126 (2006) 441-443
69. Sandberg M., Vuorio T., Hirvonen H., Alitalo K., and Vuorio E. Enhanced expression of TGF-beta and c-fos mRNAs in the growth plates of developing human long bones. Development 102 (1988) 461-470
70. Zhao C., Irie N., Takada Y., Shimoda K., Miyamoto T., Nishiwaki T., et al. Bidirectional ephrinB2-EphB4 signaling controls bone homeostasis. Cell. Metab. 4 (2006) 111-121
71. Yu G., Luo H., Wu Y., and Wu J. Ephrin B2 induces T cell costimulation. J. Immunol. 171 (2003) 106-114
72. Frost H.M. Dynamics of bone remodeling. In: Frost H.M. (Ed). Bone biodynamics (1964), Little, Brown and Co., Boston 315-333
73. Manolagas S.C. Birth and death of bone cells: basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis. Endocr. Rev. 21 (2000) 115-137
74. Matsuo K., and Irie N. Osteoclast-osteoblast communication. Arch. Biochem. Biophys. 473 (2008) 201-209
75. Hauge E.M., Qvesel D., Eriksen E.F., Mosekilde L., and Melsen F. Cancellous bone remodeling occurs in specialized compartments lined by cells expressing osteoblastic markers. J. Bone Miner. Res. 16 (2001) 1575-1582
76. Parfitt A.M. The bone remodeling compartment: a circulatory function for bone lining cells. J. Bone Miner. Res. 16 (2001) 1583-1585
77. Karsdal M.A., Martin T.J., Bollerslev J., Christiansen C., and Henriksen K. Are nonresorbing osteoclasts sources of bone anabolic activity?. J. Bone Miner. Res. 22 (2007) 487-494
78. Marks Jr. S.C., and Lane P.W. Osteopetrosis, a new recessive skeletal mutation on chromosome 12 of the mouse. J. Hered. 67 (1976) 11-18
79. Begg S.K., Radley J.M., Pollard J.W., Chisholm O.T., Stanley E.R., and Bertoncello I. Delayed hematopoietic development in osteopetrotic (op/op) mice. J. Exp. Med. 177 (1993) 237-242
80. Dai X.M., Ryan G.R., Hapel A.J., Dominguez M.G., Russell R.G., Kapp S., et al. Targeted disruption of the mouse colony-stimulating factor 1 receptor gene results in osteopetrosis, mononuclear phagocyte deficiency, increased primitive progenitor cell frequencies, and reproductive defects. Blood 99 (2002) 111-120
81. Nishino I., Amizuka N., and Ozawa H. Histochemical examination of osteoblastic activity in op/op mice with or without injection of recombinant M-CSF. J. Bone Miner. Metab. 19 (2001) 267-276
82. Dai X.M., Zong X.H., Akhter M.P., and Stanley E.R. Osteoclast deficiency results in disorganized matrix, reduced mineralization, and abnormal osteoblast behavior in developing bone. J. Bone Miner. Res. 19 (2004) 1441-1451
83. Lee S.H., Rho J., Jeong D., Sul J.Y., Kim T., Kim N., et al. v-ATPase V0 subunit d2-deficient mice exhibit impaired osteoclast fusion and increased bone formation. Nat. Med. 12 (2006) 1403-1409
84. Rho J., Altmann C.R., Socci N.D., Merkov L., Kim N., So H., et al. Gene expression profiling of osteoclast differentiation by combined suppression subtractive hybridization (SSH) and cDNA microarray analysis. DNA Cell. Biol. 21 (2002) 541-549
85. Stanley E.R., Berg K.L., Einstein D.B., Lee P.S., Pixley F.J., Wang Y., et al. Biology and action of colony-stimulating factor-1. Mol. Reprod. Dev. 46 (1997) 4-10
86. Li X., Ominsky M.S., Niu Q.T., Sun N., Daugherty B., D'Agostin D., et al. Targeted deletion of the sclerostin gene in mice results in increased bone formation and bone strength. J. Bone Miner. Res. 23 (2008) 860-869
87. Feeley B.T., Liu N.Q., Conduah A.H., Krenek L., Roth K., Dougall W.C., et al. Mixed metastatic lung cancer lesions in bone are inhibited by noggin overexpression and Rank:Fc administration. J. Bone Miner. Res. 21 (2006) 1571-1580